Validating performance status and activities of daily living assessment tools for Chinese palliative care in a cancer setting: A cross-cultural psychometric study

验证适用于中国癌症姑息治疗患者的功能状态和日常生活活动能力评估工具:一项跨文化心理测量学研究

阅读:1

Abstract

OBJECTIVE: National approaches to the routine assessment of palliative care patients improve patient outcomes. However, validated tools and a national methodology for this are lacking in Mainland China. The Australian Palliative Care Outcomes Collaboration (PCOC) model is a well-established national program aimed at improving the quality of palliative care based on point-of-care outcomes assessment. This study aimed to culturally adapt and validate two measures used in PCOC (Australia-modified Karnofsky Performance Status [AKPS], Resource Utilization Groups - Activities of Daily Living [RUG-ADL]) in the Chinese context. METHODS: A cross-cultural adaptation and validation study involving forward and backward translation methods, cognitive interviewing, and psychometric testing. RESULTS: Two minor adjustments were made to the scoring instructions for the RUG-ADL, and the AKPS remained unchanged. Twenty-two clinicians participated in psychometric testing, completing 363 paired assessments on 135 inpatients. The correlations between AKPS and the Barthel index (BI) for activities of daily living (r = 0.77, P < 0.001), AKPS and RUG-ADL (r = -0.82, P < 0.001), RUG-ADL and BI (r = -0.67 to -0.76) demonstrated good concurrent validity for both the AKPS and the RUG-ADL. The inter-rater reliability for AKPS (k = 0.63) and RUG-ADL were substantial and moderate (k = 0.51-0.56), respectively. The RUG-ADL also showed good internal consistency (Cronbach's alpha = 0.92). Both tools were able to detect patients' urgent needs. CONCLUSIONS: The Chinese version of AKPS and RUG-ADL can be systematically used to assess performance status and dependency among palliative care patients. However, observational assessments and enhanced communication between clinicians and patients/caregivers is also recommended for optimal clinical utility.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。